Aiming to revolutionise prostate cancer detection and treatment, Apollo Hospital Seshadripuram has introduced a novel technology, MRI Fusion TRUS guided Trans-Perineal Targeted Biopsy, that enhances the accuracy of cancer detection by 95 to 97%. Dr Manohar T, Chief of Urology at Apollo Hospital Seshadripuram, who has successfully conducted 42 procedures using MRI Fusion TRUS guided Trans-Perineal Targeted Biopsy, said, “In this procedure, one has to undergo multi-parametric MRI and contouring of the lesions which are suspected to be cancerous, and prostate size is marked via a special software pack.
The image is then transferred to the special ultrasound done trans-rectally.” Explaining the benefits of this latest technology, Dr Manohar T said: “Early diagnosis is critical in improving the outcomes. Conventional investigation methods miss the diagnosis by 35-45%.”
source/content: newindianexpress.com (headline edited)